tradingkey.logotradingkey.logo
优惠
Tradingkey

Windward Bio Group Ord Shs

WWB
添加自选
24.285USD
+0.275+1.15%
收盘 11-20 16:00(美东)
0.00总市值
--市盈率 TTM

Windward Bio Group Ord Shs

24.285
+0.275+1.15%

关于 Windward Bio Group Ord Shs 公司

Windward Bio AG is a Switzerland-based company primarily engaged in the biotechnology and biopharmaceutical industry. The Company focuses on the development of ultra-long-acting antibody medicines for immunological, respiratory, and dermatologic diseases, including asthma, chronic obstructive pulmonary disease (COPD), and atopic dermatitis. Their key product is WIN378, which is a monoclonal antibody therapeutic that targets thymic stromal lymphopoietin (TSLP). It aims to reduce inflammation associated with respiratory diseases and provide longer dosing intervals for patients. The Company is also developing WIN027, a bispecific antibody targeting TSLP and interleukin-13 (IL-13) for immunological disorders.

Windward Bio Group Ord Shs 简介

公司代码WWB
公司名称Windward Bio AG
上市日期Nov 13, 2026
CEOSantarelli (Luca)
员工数量- -
证券类型Ordinary Share
年结日- -
公司地址Aeschenplatz 6
城市BASEL
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Switzerland
邮编4052
电话41615517575
网址https://windwardbio.com/
公司代码WWB
上市日期Nov 13, 2026
CEOSantarelli (Luca)

Windward Bio Group Ord Shs公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Kevin Harris
Mr. Kevin Harris
Chief Operating Officer
Chief Operating Officer
960.97K
--
Mr. Kevin Harris
Mr. Kevin Harris
Chief Operating Officer
Chief Operating Officer
960.97K
--
Mr. Kevin Harris
Mr. Kevin Harris
Chief Operating Officer
Chief Operating Officer
960.97K
--
Mr. Kevin Harris
Mr. Kevin Harris
Chief Operating Officer
Chief Operating Officer
960.97K
--
Mr. Luca Santarelli, M.D.
Mr. Luca Santarelli, M.D.
Founder, Chief Executive Officer, Board Chair
Founder, Chief Executive Officer, Board Chair
--
--
Mr. Michael Steininger
Mr. Michael Steininger
Head of Human Resources
Head of Human Resources
--
--
Ms. Martine Mazzetti, Ph.D.
Ms. Martine Mazzetti, Ph.D.
Chief of Staff
Chief of Staff
--
--
Ms. Claudia D'augusta, Ph.D.
Ms. Claudia D'augusta, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Scott Applebaum
Mr. Scott Applebaum
Chief Legal, Business Officer
Chief Legal, Business Officer
--
--
Mr. Omar Khwaja, M.D., Ph.D.
Mr. Omar Khwaja, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Kevin Harris
Mr. Kevin Harris
Chief Operating Officer
Chief Operating Officer
960.97K
--
Mr. Kevin Harris
Mr. Kevin Harris
Chief Operating Officer
Chief Operating Officer
960.97K
--
Mr. Kevin Harris
Mr. Kevin Harris
Chief Operating Officer
Chief Operating Officer
960.97K
--
Mr. Kevin Harris
Mr. Kevin Harris
Chief Operating Officer
Chief Operating Officer
960.97K
--
Mr. Luca Santarelli, M.D.
Mr. Luca Santarelli, M.D.
Founder, Chief Executive Officer, Board Chair
Founder, Chief Executive Officer, Board Chair
--
--
Mr. Michael Steininger
Mr. Michael Steininger
Head of Human Resources
Head of Human Resources
--
--
tradingkey.logotradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有